This is the authors' abstract. We don't add key points for this paper.
In conjunction with the growing availability of large-scale genomic databases, higher level of automation and increased robustness of the methods, MR promises to be a valuable strategy to examine causality in complex biological/omics networks, inform drug development and prioritize intervention targets for disease prevention in the future.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: